DelveInsight’s "Muscle Spasticity Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Muscle Spasticity pipeline landscape. It covers the ...

The global paediatric spasticity treatment industry is expected to reach growing at a CAGR of 10% from 2022 to 2032. Paediatric spasticity is a condition characterized by increased muscle tone and ...

The global Spasticity Treatment Market is worth US$ 13.1 Billion as of now and is expected to reach US$ 28.4 Billion by the year 2033 at a CAGR of 8.1% between 2023 and 2033. Spasticity is turning out ...

"Spasticity Pipeline Insight"The spasticity treatment pipeline is rapidly evolving to meet the need for safer, longer-lasting, and more targeted therapies. Common in conditions like cerebral palsy, MS ...

BURLINGTON, Ontario--(BUSINESS WIRE)--Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, today announced that Health Canada approved XEOMIN ® (incobotulinumtoxinA) ...

Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...

U.S. regulators have issued warnings to 18 websites that were selling fake or unapproved versions of Botox and similar wrinkle-relaxing injections. Researchers at the University of Ottawa have made a ...

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Spasticity Treatment Market 2024-2028" report has been added to ResearchAndMarkets.com's offering. The global spasticity treatment market is ...